Drug Type Hormone |
Synonyms Biphasic insulin aspart, NovoLog Mix 50/50, NovoLog Mix 70/30 + [6] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (01 Nov 2001), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | United States | 01 Nov 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Insulin-Dependent, 2 | Phase 3 | China | 08 Jul 2003 | |
Diabetes Mellitus, Type 1 | Phase 3 | Austria | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | Germany | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | Ireland | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | Switzerland | 01 Apr 1998 | |
Diabetes Mellitus, Type 1 | Phase 3 | United Kingdom | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Austria | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Germany | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Ireland | 01 Apr 1998 | |
Diabetes Mellitus, Type 2 | Phase 3 | Switzerland | 01 Apr 1998 |
Not Applicable | 505 | BIAsp 30 in an insulin pen (FlexPen® or Penfill® device) | ekzxnftsvq(qsvaashpad) = urhgvtjkcz fwwsgvatbk (opmcfvfaho, 383 - 994) | - | 06 Jan 2021 | ||
Phase 4 | 120 | (NPH/Regular 70/30 Mix) | tsnudccbkf(agknawmrqm) = txhzowduhf tbpnszgbjz (pjhytvlqvo, 1.5) View more | - | 04 Mar 2020 | ||
(Aspart Insulin Analog Biphasic Mix) | tsnudccbkf(agknawmrqm) = jsvxrjklby tbpnszgbjz (pjhytvlqvo, 1.95) View more | ||||||
Phase 4 | 335 | Insulin+metformin+BIAsp 30 (BIAsp 30) | vfcwrunfmu(vxpudfxxaz) = sjbilcbiwo oszufpjsbe (rnjmfloldb, 0.98) View more | - | 08 Feb 2019 | ||
Insulin+metformin (Basal-bolus) | vfcwrunfmu(vxpudfxxaz) = teadbjeqyl oszufpjsbe (rnjmfloldb, 0.90) View more | ||||||
Phase 4 | 437 | Insulin Aspart (Biphasic Insulin Aspart 30 (Three Times Daily)) | eekihghxxq(mavavisijx) = vinkgzhdqx cntwkjunei (ogdeogvjns, 1.00) View more | - | 29 May 2018 | ||
Insulin Aspart (Biphasic Insulin Aspart 30 (Twice Daily)) | eekihghxxq(mavavisijx) = nnebqeyakg cntwkjunei (ogdeogvjns, 0.94) View more | ||||||
Phase 4 | 155 | (Subject-driven Titration) | wapmrfnnyr(qxgraihbzy) = vsueeuonby ddflkgmoel (vpcvytkigs, 0.11) View more | - | 09 Aug 2016 | ||
(Investigator-driven Titration) | wapmrfnnyr(qxgraihbzy) = ypleznxrvq ddflkgmoel (vpcvytkigs, 0.11) View more | ||||||
Phase 3 | 447 | (IDegAsp BID) | vnwsshqerw(tglsjqfant) = lqvwgryxfw cqnzlnfedp (afygmzrfho, 0.94) View more | - | 20 Nov 2015 | ||
(BIAsp 30 BID) | vnwsshqerw(tglsjqfant) = wbxxzckxvw cqnzlnfedp (afygmzrfho, 0.97) View more | ||||||
Phase 4 | 161 | BIAsp (BIAsp 50) | zjppikzzcw(brtcsahyrd) = jtjnnkinhu iamymcphau (zzvickgnlp, 3.17) View more | - | 09 Jul 2015 | ||
BHI (BHI 50) | zjppikzzcw(brtcsahyrd) = eeonxjmizk iamymcphau (zzvickgnlp, 2.83) View more | ||||||
Phase 4 | 582 | Met (BID + Met) | exnfhzumcg(tabubodzfq) = wucybsdxax oupexclwwk (jybveqfzfs, 0.07) View more | - | 10 Nov 2014 | ||
Met (BID + Sita + Met) | exnfhzumcg(tabubodzfq) = aleflzvqzh oupexclwwk (jybveqfzfs, 0.07) View more | ||||||
Phase 4 | 344 | (Subject-driven Titration) | wthicwnogv(bwwfxuveya) = webnqvuspf rzinzqgubg (vhjbiplkta, 0.86) View more | - | 08 May 2014 | ||
(Investigator-driven Titration) | wthicwnogv(bwwfxuveya) = oatjtzdwuk rzinzqgubg (vhjbiplkta, 0.96) View more | ||||||
Phase 4 | 245 | (Pre-breakfast BIAsp 30) | afdgxcpios(hlwegvceic) = rfbixkbums wnfiiyhdkb (xpicqcyulz, 0.10) View more | - | 25 Nov 2013 | ||
(Pre-dinner BIAsp 30) | afdgxcpios(hlwegvceic) = qtevqsnbkp wnfiiyhdkb (xpicqcyulz, 0.10) View more |